We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

ProtoKinetix

News  
Published: February 1, 2008 
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

By submitting your email address, you agree to receive email communications related to Technology Networks content, products, or our partners. You may unsubscribe from these communications at any time as we respect your privacy. View our Privacy Policy for more information.
Read time: Less than a minute
ProtoKinetix owns the world-wide rights to a family of anti-aging glycoproteins, trademarked as  AAGPs™. In clinical tests AAGPs™ have demonstrated the ability to enhance the health and extend the life of biologically sensitive cells which have been subjected to severe stress conditions under laboratory controlled tests. AAGPs™ are stable and non-toxic.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter